Literature DB >> 9032492

Consequences of occupational asthma on employment and financial status: a follow-up study.

J Ameille1, J C Pairon, M C Bayeux, P Brochard, D Choudat, F Conso, A Devienne, R Garnier, Y Iwatsubo.   

Abstract

The aim of this study was to describe changes in employment and income following a diagnosis of occupational asthma, and to determine what factors might affect these changes. Two hundred and nine patients with occupational asthma were reviewed on average 3.1 yrs after the diagnosis had been made. They were contacted by telephone or were sent a self-administered questionnaire by post. Multiple logistic regression models were constructed to determine which variables were associated with loss of employment after the diagnosis. At the time of review, 44% of patients had left their previous job and 25% were currently unemployed. Remarkably, 32% remained exposed to the offending agents in the same job. Forty six percent of the patients had suffered a reduction of income (84% of those who had left their employer versus 19% of those still employed in the same company (p < 0.001)). Claims for compensation, size of the company, level of education, and age at the time of diagnosis were significantly associated with a risk for becoming unemployed or having a new employer after the diagnosis of occupational asthma. Occupational asthma results in severe socioeconomic consequences. The French compensation system for occupational asthma should be revised, as the criteria currently used to determine compensation for this disease largely underestimate the social and occupational damages.

Entities:  

Mesh:

Year:  1997        PMID: 9032492     DOI: 10.1183/09031936.97.10010055

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  20 in total

1.  Health-related quality of life among adults with work-related asthma in the United States.

Authors:  Gretchen E Knoeller; Jacek M Mazurek; Jeanne E Moorman
Journal:  Qual Life Res       Date:  2012-06-04       Impact factor: 4.147

2.  Work-related asthma and employment status--38 states and District of Columbia, 2006-2009.

Authors:  Gretchen E White; Jacek M Mazurek; Jeanne E Moorman
Journal:  J Asthma       Date:  2013-08-21       Impact factor: 2.515

3.  Prevalence and risk factors for work related asthma in young adults.

Authors:  R D Caldeira; H Bettiol; M A Barbieri; J Terra-Filho; C A Garcia; E O Vianna
Journal:  Occup Environ Med       Date:  2006-05-25       Impact factor: 4.402

4.  Factors associated with severity of occupational asthma with a latency period at diagnosis.

Authors:  A Descatha; H Leproust; D Choudat; R Garnier; J-C Pairon; J Ameille
Journal:  Allergy       Date:  2007-07       Impact factor: 13.146

Review 5.  Occupational asthma. Practical points for diagnosis and management.

Authors:  W G Kuschner; R K Chitkara; P S Sarinas
Journal:  West J Med       Date:  1998-12

6.  Work-related asthma among adults with current asthma in 33 states and DC: evidence from the Asthma Call-Back Survey, 2006-2007.

Authors:  Gretchen E Knoeller; Jacek M Mazurek; Jeanne E Moorman
Journal:  Public Health Rep       Date:  2011 Jul-Aug       Impact factor: 2.792

7.  Asthma related to workplace dampness and impaired work ability.

Authors:  Kirsi Karvala; Henrik Nordman; Ritva Luukkonen; Jukka Uitti
Journal:  Int Arch Occup Environ Health       Date:  2012-12-04       Impact factor: 3.015

8.  When should specific occupational challenge tests be performed?

Authors:  Susan M Tarlo
Journal:  Chest       Date:  2013-05       Impact factor: 9.410

9.  Assessing and treating work-related asthma.

Authors:  Tracy Stoughton; Michael Prematta; Timothy Craig
Journal:  Allergy Asthma Clin Immunol       Date:  2008-12-15       Impact factor: 3.406

10.  Patient-physician communication about work-related asthma: what we do and do not know.

Authors:  Jacek M Mazurek; Gretchen E White; Jeanne E Moorman; Eileen Storey
Journal:  Ann Allergy Asthma Immunol       Date:  2014-12-06       Impact factor: 6.347

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.